FDA Tries To Break Precedent, Pull Unproven Blood Pressure Drug

FDA Tries To Break Precedent, Pull Unproven Blood Pressure Drug

The Food and Drug Administration is moving to pull ProAmatine, a blood pressure medication that’s been available for 14 years and racked up a quarter billion in sales, because the manufacturer hasn’t submitted a follow-up study that proves the drug is effective. [More]